An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
Clinical trial NCT06664814 · RECRUITING
Trial details
- NCT number
- NCT06664814
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-23
- Primary completion
- 2027-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.